tiprankstipranks
Trending News
More News >
Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
US Market

Poniard Pharmaceuticals (PARD) Income Statement

Compare
7 Followers

Poniard Pharmaceuticals Income Statement

Last quarter (Q0 0), Poniard Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Poniard Pharmaceuticals's net income was $-3.77M. See Poniard Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 10Dec 09Dec 08Dec 07Dec 06
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 0.00$ 0.00$ 0.00$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -25.02M$ -38.97M$ -47.55M$ -34.22M$ -17.02M
Operating Income
$ -26.33M$ -40.44M$ -49.16M$ -35.35M$ -21.23M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -30.05M$ -45.72M$ -48.56M$ -32.78M$ -23.29M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Poniard Pharmaceuticals Earnings and Revenue History